Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Livia Biancone, Sandro Ardizzone, Alessandro Armuzzi, Fabiana Castiglione, Renata D’Incà, Silvio Danese, Marco Daperno, Paolo Gionchetti, Fernando Rizzello, Maria Lia Scribano, Maurizio Vecchi & Ambrogio Orlando. (2020) Ustekinumab for treating ulcerative colitis: an expert opinion. Expert Opinion on Biological Therapy 20:11, pages 1321-1329.
Read now
Read now
Paulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi & Remo Panaccione. (2018) Clinical utility of ustekinumab in Crohn’s disease. Journal of Inflammation Research 11, pages 35-47.
Read now
Read now
Shannon Chang & Stephen Hanauer. (2017) Optimizing pharmacologic management of inflammatory bowel disease. Expert Review of Clinical Pharmacology 10:6, pages 595-607.
Read now
Read now
Articles from other publishers (35)
Aleksandra Korta, Julia Kula & Krzysztof Gomułka. (2023) The Role of IL-23 in the Pathogenesis and Therapy of Inflammatory Bowel Disease. International Journal of Molecular Sciences 24:12, pages 10172.
Crossref
Crossref
Mounzer Koudsi, Christine Martinez-Vinson, Bénédicte Pigneur, Stéphanie Willot, Djeddi Djamal, Raphael Enaud, Julie Rebeuh, Claire Dupont, Alain Dabadie, Valérie Bertrand, Jean-Pierre Hugot, Alain Lachaux, Franck Ruemmele, Jérôme Viala, Rémi Duclaux-Loras & GETAID Pédiatrique. (2023) Ustekinumab Use in Pediatric Inflammatory Bowel Disease: A French Multicenter Study From the Pediatric GETAID. Journal of Pediatric Gastroenterology & Nutrition 76:6, pages 763-770.
Crossref
Crossref
Nashwa Eltantawy, Islam Abd El-Hamid El-Zayyadi, Ahmed A. Elberry, Layla M. Salah, Mohamed E. A. Abdelrahim & Amira B. Kassem. (2023) A review article of inflammatory bowel disease treatment and pharmacogenomics. Beni-Suef University Journal of Basic and Applied Sciences 12:1.
Crossref
Crossref
Letizia Masi, Cristina Ciuffini, Valentina Petito, Laura Francesca Pisani, Loris Riccardo Lopetuso, Cristina Graziani, Daniela Pugliese, Lucrezia Laterza, Pierluigi Puca, Federica Di Vincenzo, Marco Pizzoferrato, Daniele Napolitano, Laura Turchini, Valeria Amatucci, Elisa Schiavoni, Giuseppe Privitera, Laura Maria Minordi, Maria Chiara Mentella, Alfredo Papa, Alessandro Armuzzi, Antonio Gasbarrini & Franco Scaldaferri. (2022) Innovative, complementary and alternative therapy in inflammatory bowel diseases: A broad 2020s update. Frontiers in Gastroenterology 1.
Crossref
Crossref
Mansour Altuwaijri, Loai Hakami, Othman Alharbi, Majid Almadi, Suliman Alshankiti, Abdulrahman Aljebreen & Nahla Azzam. (2022) The Long-Term Clinical Effectiveness of Ustekinumab in Antitumor Necrosis Factor-Experienced Crohn’s Disease Patients. Cureus.
Crossref
Crossref
Tatjana Hoffmann, Stefano Fusco, Gunnar Blumenstock, Saman Sadik, Nisar P Malek & Eckhart Froehlich. (2020) Evaluation of bowel wall thickness by ultrasound as early diagnostic tool for therapeutic response in Crohn’s disease patients treated with ustekinumab. Zeitschrift für Gastroenterologie 60:08, pages 1212-1220.
Crossref
Crossref
Nerissa T. Viola, James E. Glassbrook, Jhansi R. Kalluri, Justin B. Hackett, Madison N. Wicker, Joshua Sternberg & Heather M. Gibson. (2022) Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses. Frontiers in Immunology 13.
Crossref
Crossref
Manrong He, Chao Li, Wanxin Tang, Yingxi Kang, Yongdi Zuo & Yufang Wang. (2021) Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease. Immunity, Inflammation and Disease 9:4, pages 1529-1540.
Crossref
Crossref
Mahmoud A. Ghannoum, Thomas S. McCormick, Mauricio Retuerto, Gurkan Bebek, Susan Cousineau, Lynn Hartman, Charles Barth & Kory Schrom. (2021) Evaluation of Microbiome Alterations Following Consumption of BIOHM, a Novel Probiotic. Current Issues in Molecular Biology 43:3, pages 2135-2146.
Crossref
Crossref
Amanda Nash, Samira Aghlara-Fotovat, Andrea Hernandez, Christopher Scull & Omid Veiseh. (2021) Clinical translation of immunomodulatory therapeutics. Advanced Drug Delivery Reviews 176, pages 113896.
Crossref
Crossref
Antonello Di Paolo & Giacomo Luci. (2021) Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond. Frontiers in Pharmacology 11.
Crossref
Crossref
Sindhuri Upadrasta & Vikas Yadav. 2021. Translational Biotechnology. Translational Biotechnology
347
369
.
Isaiah P. Schuster, Leslie Klyachman, Ramona Rajapakse & Farah Monzur. 2021. Inflammatory Bowel Disease. Inflammatory Bowel Disease
89
114
.
Marisa Iborra, Belén Beltrán, Agnes Fernández‐Clotet, Eva Iglesias‐Flores, Pablo Navarro, Montserrat Rivero, Ana Gutiérrez, Mónica Sierra‐Ausin, Francisco Mesonero, Rocío Ferreiro‐Iglesias, Joaquín Hinojosa, Xavier Calvet, Beatriz Sicilia, Carlos González‐Muñoza, Beatriz Antolín, María González‐Vivo, Ana Y. Carbajo, Santiago García‐López, Albert Martín‐Cardona, Gerard Surís, María Dolores Martin‐Arranz, Ruth de Francisco, Fiorella Cañete, Eugeni Domènech & Pilar Nos. (2020) Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry. Alimentary Pharmacology & Therapeutics 52:6, pages 1017-1030.
Crossref
Crossref
Michael W. Winter & Joel V. Weinstock. 2020. The Autoimmune Diseases. The Autoimmune Diseases
871
894
.
Konstantinos H. Katsanos, Konstantinos Papamichael, Joseph D. Feuerstein, Dimitrios K. Christodoulou & Adam S. Cheifetz. (2019) Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies. Clinical Immunology 206, pages 9-14.
Crossref
Crossref
Piercarlo Sarzi-Puttini, Angela Ceribelli, Daniela Marotto, Alberto Batticciotto & Fabiola Atzeni. (2019) Systemic rheumatic diseases: From biological agents to small molecules. Autoimmunity Reviews 18:6, pages 583-592.
Crossref
Crossref
Subrata Ghosh, Brian Bressler, Jill Petkau, Roopal B. Thakkar, Song Wang, Martha Skup, Jingdong Chao, Remo Panaccione & Stefan Schreiber. (2019) Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s Disease. Digestive Diseases and Sciences 64:5, pages 1142-1149.
Crossref
Crossref
Mallory Chavannes, Christine Martinez-Vinson, Lara Hart, Nicole Kaniki, Che-Yung Chao, Sally Lawrence, Kevan Jacobson, Jean-Pierre Hugot, Jérome Viala, Colette Deslandres, Prevost Jantchou & Ernest G Seidman. (2019) Management of Paediatric Patients With Medically Refractory Crohn’s Disease Using Ustekinumab: A Multi-Centred Cohort Study. Journal of Crohn's and Colitis 13:5, pages 578-584.
Crossref
Crossref
Linda M Rehaume, Nicholas Matigian, Ahmed M Mehdi, Nancy Lachner, Kate L Bowerman, Joshua Daly, Kim-Anh Lê Cao, Philip Hugenholtz & Ranjeny Thomas. (2019) IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota. Annals of the Rheumatic Diseases 78:4, pages 494-503.
Crossref
Crossref
Filipe Martins, Gerasimos P Sykiotis, Michel Maillard, Montserrat Fraga, Camillo Ribi, Thierry Kuntzer, Olivier Michielin, Solange Peters, Georges Coukos, Francois Spertini, John A Thompson & Michel Obeid. (2019) New therapeutic perspectives to manage refractory immune checkpoint-related toxicities. The Lancet Oncology 20:1, pages e54-e64.
Crossref
Crossref
Katherine Falloon & Mark Lazarev. 2019. Molecular Genetics of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease
3
24
.
Helena Jenkinson, Lindsay Thelin, Rachel McAndrew, Krystal M. Jones, L. Brent Talbott & Dayna Diven. (2018) Cutaneous protothecosis in a patient on ustekinumab for psoriasis. International Journal of Dermatology 57:10, pages 1246-1248.
Crossref
Crossref
Luc J. J. Derijks, Dennis R. Wong, Daniel W. Hommes & Adriaan A. van Bodegraven. (2018) Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease. Clinical Pharmacokinetics 57:9, pages 1075-1106.
Crossref
Crossref
Bo-Lin Yang, Ping Zhu, You-Ran Li, Min-Min Xu, Hao Wang, Li-Chao Qiao, Hai-Xia Xu & Hong-Jin Chen. (2018)
Total flavone of
Abelmoschus manihot
suppresses epithelial-mesenchymal transition
via
interfering transforming growth factor-β1 signaling in Crohn’s disease intestinal fibrosis
. World Journal of Gastroenterology 24:30, pages 3414-3425.
Crossref
Crossref
M.J. Gooderham, K.A. Papp & C.W. Lynde. (2018)
Shifting the focus – the primary role of
IL
‐23 in psoriasis and other inflammatory disorders
. Journal of the European Academy of Dermatology and Venereology 32:7, pages 1111-1119.
Crossref
Crossref
Satoshi Tanida, Tsutomu Mizoshita, Keiji Ozeki, Takahito Katano, Mamoru Tanaka, Hirotada Nishie, Takaya Shimura, Yasuyuki Okamoto, Eiji Kubota, Hiromi Kataoka & Takashi Joh. (2018) Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease. Therapeutic Apheresis and Dialysis 22:3, pages 295-300.
Crossref
Crossref
Milan Buc. (2018) Current and prospective biologics and small molecules in the treatment of inflammatory bowel diseases. Vnitřní lékařství 64:3, pages 280-289.
Crossref
Crossref
Fernando Velayos. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics
303
313
.
Yi Li, Yihao Wang, Hui Liu, Kai Ding, Shanfeng Hao, Yuanyuan Shao, Honglei Wang, Jin Chen, Lei Huang, Zonghong Shao & Rong Fu. (2017) Lower level of IL‑35 and its reduced inhibition in Th17 cells in patients with bone marrow mononuclear cells Coombs test‑positive hemocytopenia. Molecular Medicine Reports.
Crossref
Crossref
Jiayin Yao, Yi Lu, Min Zhi, Pinjin Hu, Wei Wu & Xiang Gao. (2017) Dietary n-3 polyunsaturated fatty acids ameliorate Crohn's disease in rats by modulating the expression of PPAR-γ/NFAT. Molecular Medicine Reports 16:6, pages 8315-8322.
Crossref
Crossref
Parakkal Deepak & William J. Sandborn. (2017) Ustekinumab and Anti-Interleukin-23 Agents in Crohn's Disease. Gastroenterology Clinics of North America 46:3, pages 603-626.
Crossref
Crossref
Diego Currò, Daniela Pugliese & Alessandro Armuzzi. (2017) Frontiers in Drug Research and Development for Inflammatory Bowel Disease. Frontiers in Pharmacology 8.
Crossref
Crossref
Parakkal Deepak, Sang Hyoung Park, Eric C. Ehman, Stephanie L. Hansel, Jeff L. Fidler, David H. Bruining & Joel G. Fletcher. (2017) Crohn’s disease diagnosis, treatment approach, and management paradigm: what the radiologist needs to know. Abdominal Radiology 42:4, pages 1068-1086.
Crossref
Crossref
Ali Salaritabar, Behrad Darvishi, Farzaneh Hadjiakhoondi, Azadeh Manayi, Antoni Sureda, Seyed Fazel Nabavi, Leo R Fitzpatrick, Seyed Mohammad Nabavi & Anupam Bishayee. (2017) Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review. World Journal of Gastroenterology 23:28, pages 5097.
Crossref
Crossref